Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Дегенеративное поражение позвоночника и боль в спине: подходы к терапии
Дегенеративное поражение позвоночника и боль в спине: подходы к терапии
Шостак Н.А., Правдюк Н.Г., Клименко А.А., Кондрашов А.А., Егорова В.А., Швырева Н.М. Дегенеративное поражение позвоночника и боль в спине: подходы к терапии. Consilium Medicum. 2013; 15 (2): 37–40.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Antoniou J, Steffen T, Nelson F et al. The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest 1996; 98 (4): 996–1003.
2. Milette PC. The proper terminology for reporting lumbar intervertebral disk disorders. AJNR Am J Neuroradiol 1997; 18: 1859–66.
3. Burke JG, Watson RWG, McCormack D et al. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br 2002; 84 (2): 196–201.
4. Manek NJ, MacGregor AJ. Epidemiology of Back Disorders: prevalence, risk factors, and prognosis. Сurr Opin Rheumatol 2005; 17 (2): 134–40.
5. Martin MD, Boxell CM, Malone DG. Pathophysiology of Lumbar Disc Degeneration: A Review of the Literature. Neurosurgical Focus 2002; 13 (2): www.medscape.com/viewarticle/442440.
6. Fardon DF, Milette PC. Nomenclature and classification of lumbar disk pathology: recommendations of the combined task forces of the North Am Spine Soc, Am Soc Spine Radiol, Am Soc Neuroradiol 2001; 26: 93–113.
7. Хелимский А.М. Хронические дискогенные болевые синдромы шейного и поясничного остеохондроза. Хабаровск: Риотип, 2000.
8. Шостак Н.А. Дорсопатии – совершенствование терапевтических возможностей. Трудный пациент. 2006; 10: 24–30.
9. Jerosch J. Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids. Int J Rheumatol 2011: 969 012.
10. Pecchi E, Priam S, Mladenovic Z et al. A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E2 and matrix metalloproteinases synthesis in interleukin-1b-stimulated osteoblasts.
Osteoarthritis Cartilage 2012; 20 (2): 127–35.
11. Bauerova K, Ponist S, Kuncirova V et al. Chondroitin sulfate effect on induced arthritis in rats. Osteoarthritis Cartilage 2011; 19 (11): 1373–9.
12. Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 2005; 7 (4): R732–45.
13. Hoyland JA, Le Maitre C, Freemont AJ. Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology 2008; 47 (6): 809–14.
14. Zhang R, Ruan D, Zhang C. Effects of TGF-beta1 and IGF-1 on proliferation of human nucleus pulposus cells in medium with different serum concentrations. J Orthop Surg Res 2006; 26: 1–9.
15. Bachmeier BE, Nerlich A, Mittermaier N et al. Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration. Eur Spine J 2009; 18 (11): 1573–86.
16. Ohtori S, Inoue G, Ito T et al. Tumor necrosis factor-immunoreactive cells and PGP 9.5-immunoreactive nerve fibers in vertebral endplates of patients with discogenic low back pain and Modic Type 1 or Type 2 changes on MRI. Spine 2006; 31 (9): 1026–31.
17. Power C, Frank J, Hertzman C et al. Predictors of low back pain onset in a prospective British study. Am J Public Health 2001; 91 (10): 1671–8.
18. Алексеева Л.И., Чичасова Н.В., Мендель О.И. и др. Рациональный выбор базисной терапии при остеоартрозе. Результаты открытого рандомизированного многоцентрового исследования препарата Артра в России. РМЖ. 2005; 13 (24): 1637–40.
19. Cole TC, Ghosh P, Taylor TKF. Arteparon modifies proteoglican turnover in the intervertebral disk. J Bone J Sure 1998; 70B: 166.
20. Blitterswijk WJ, Jos CM van de Nes, Wuisman P. Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: Biochemical rationale and case report. BMC Complement Altern Med 2003; 3: 2.
2. Milette PC. The proper terminology for reporting lumbar intervertebral disk disorders. AJNR Am J Neuroradiol 1997; 18: 1859–66.
3. Burke JG, Watson RWG, McCormack D et al. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br 2002; 84 (2): 196–201.
4. Manek NJ, MacGregor AJ. Epidemiology of Back Disorders: prevalence, risk factors, and prognosis. Сurr Opin Rheumatol 2005; 17 (2): 134–40.
5. Martin MD, Boxell CM, Malone DG. Pathophysiology of Lumbar Disc Degeneration: A Review of the Literature. Neurosurgical Focus 2002; 13 (2): www.medscape.com/viewarticle/442440.
6. Fardon DF, Milette PC. Nomenclature and classification of lumbar disk pathology: recommendations of the combined task forces of the North Am Spine Soc, Am Soc Spine Radiol, Am Soc Neuroradiol 2001; 26: 93–113.
7. Хелимский А.М. Хронические дискогенные болевые синдромы шейного и поясничного остеохондроза. Хабаровск: Риотип, 2000.
8. Шостак Н.А. Дорсопатии – совершенствование терапевтических возможностей. Трудный пациент. 2006; 10: 24–30.
9. Jerosch J. Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids. Int J Rheumatol 2011: 969 012.
10. Pecchi E, Priam S, Mladenovic Z et al. A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E2 and matrix metalloproteinases synthesis in interleukin-1b-stimulated osteoblasts.
Osteoarthritis Cartilage 2012; 20 (2): 127–35.
11. Bauerova K, Ponist S, Kuncirova V et al. Chondroitin sulfate effect on induced arthritis in rats. Osteoarthritis Cartilage 2011; 19 (11): 1373–9.
12. Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 2005; 7 (4): R732–45.
13. Hoyland JA, Le Maitre C, Freemont AJ. Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology 2008; 47 (6): 809–14.
14. Zhang R, Ruan D, Zhang C. Effects of TGF-beta1 and IGF-1 on proliferation of human nucleus pulposus cells in medium with different serum concentrations. J Orthop Surg Res 2006; 26: 1–9.
15. Bachmeier BE, Nerlich A, Mittermaier N et al. Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration. Eur Spine J 2009; 18 (11): 1573–86.
16. Ohtori S, Inoue G, Ito T et al. Tumor necrosis factor-immunoreactive cells and PGP 9.5-immunoreactive nerve fibers in vertebral endplates of patients with discogenic low back pain and Modic Type 1 or Type 2 changes on MRI. Spine 2006; 31 (9): 1026–31.
17. Power C, Frank J, Hertzman C et al. Predictors of low back pain onset in a prospective British study. Am J Public Health 2001; 91 (10): 1671–8.
18. Алексеева Л.И., Чичасова Н.В., Мендель О.И. и др. Рациональный выбор базисной терапии при остеоартрозе. Результаты открытого рандомизированного многоцентрового исследования препарата Артра в России. РМЖ. 2005; 13 (24): 1637–40.
19. Cole TC, Ghosh P, Taylor TKF. Arteparon modifies proteoglican turnover in the intervertebral disk. J Bone J Sure 1998; 70B: 166.
20. Blitterswijk WJ, Jos CM van de Nes, Wuisman P. Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: Biochemical rationale and case report. BMC Complement Altern Med 2003; 3: 2.
Авторы
Н.А.Шостак, Н.Г.Правдюк, А.А.Клименко, А.А.Кондрашов, В.А.Егорова, Н.М.Швырева
ГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава РФ
ГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава РФ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.